AUSTEDO XR® Medication for Tardive Dyskinesia (TD)
The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). The most common side …
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) …
AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and …
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
Austedo for Uncontrolled Movements in Huntington’s and Tardive Dyskinesia
Jul 16, 2024 · Austedo (aw-STED-oh) was approved in 2017 and is the first medicine approved to treat both tardive dyskinesia and chorea caused by Huntington’s disease.
2.1 Dosing Information The dose of AUSTEDO is determined individually for each patient based on reduction of chorea or tardive dyskinesia and tolerability. When first prescribed to patients who are …
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia Severity
Nov 12, 2025 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.
Austedo (deutetrabenazine): Uses, Dosing, and More - Healthline
Dec 18, 2025 · Learn about uses, side effects, and more for Austedo (deutetrabenazine), a drug that treats tardive dyskinesia and chorea related to Huntington’s disease.
Tardive Dyskinesia Management Risks and Therapeutic Advances
Jan 9, 2026 · Tardive dyskinesia (TD) is a chronic movement disorder that can appear after long-term treatment with dopamine receptor–blocking agents (DRBAs), especially antipsychotics used for …
AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New …
May 15, 2023 · New once-daily option for the treatment of adults with tardive dyskinesia (TD) and chorea associated with Huntington’s disease (HD) is available in 6 mg, 12 mg, and 24 mg tablet …
FDA Approves One Pill, Once-Daily Tablets of ... - Neurology live
May 30, 2024 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia and …